Cargando…

Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts

BACKGROUND: The limited proliferative ability of hepatocytes is a major limitation to meet their demand for cell-based therapy, bio-artificial liver device, and drug tests. One strategy is to amplify cells at the hepatoblast (HB) stage. However, expansion of HBs with their bipotency preserved is cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Tingcai, Chen, Yan, Zhuang, Yuanqi, Yang, Fan, Xu, Yingying, Tao, Jiawang, You, Kai, Wang, Ning, Wu, Yuhang, Lin, Xianhua, Wu, Feima, Liu, Yanli, Li, Yingrui, Wang, Guodong, Li, Yin-xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888929/
https://www.ncbi.nlm.nih.gov/pubmed/31791391
http://dx.doi.org/10.1186/s13287-019-1463-y
_version_ 1783475328876806144
author Pan, Tingcai
Chen, Yan
Zhuang, Yuanqi
Yang, Fan
Xu, Yingying
Tao, Jiawang
You, Kai
Wang, Ning
Wu, Yuhang
Lin, Xianhua
Wu, Feima
Liu, Yanli
Li, Yingrui
Wang, Guodong
Li, Yin-xiong
author_facet Pan, Tingcai
Chen, Yan
Zhuang, Yuanqi
Yang, Fan
Xu, Yingying
Tao, Jiawang
You, Kai
Wang, Ning
Wu, Yuhang
Lin, Xianhua
Wu, Feima
Liu, Yanli
Li, Yingrui
Wang, Guodong
Li, Yin-xiong
author_sort Pan, Tingcai
collection PubMed
description BACKGROUND: The limited proliferative ability of hepatocytes is a major limitation to meet their demand for cell-based therapy, bio-artificial liver device, and drug tests. One strategy is to amplify cells at the hepatoblast (HB) stage. However, expansion of HBs with their bipotency preserved is challenging. Most HB expansion methods hardly maintain the bipotency and also lack functional confirmation. METHODS: On the basis of analyzing and manipulating related signaling pathways during HB (derived from human induced pluripotent stem cells, iPSCs) differentiation and proliferation, we established a specific chemically defined cocktails to synergistically regulate the related signaling pathways that optimize the balance of HB proliferation ability and stemness maintenance, to expand the HBs and investigate their capacity for injured liver repopulation in immune-deficient mice. RESULTS: We found that the proliferative ability progressively declines during HB differentiation process. Small molecule activation of Wnt or inhibition of TGF-β pathways promoted HB proliferation but diminished their bipotency, whereas activation of hedgehog (HH) signaling stimulated proliferation and sustained HB phenotypes. A cocktail synergistically regulating the BMP/WNT/TGF-β/HH pathways created a fine balance for expansion and maintenance of the bipotency of HBs. After purification, colony formation, and expansion for 20 passages, HBs retained their RNA profile integrity, normal karyotype, and ability to differentiate into mature hepatocytes and cholangiocytes. Moreover, upon transplantation into liver injured mice, the expanded HBs could engraft and differentiate into mature human hepatocytes and repopulate liver tissue with restoring hepatocyte mass. CONCLUSION: Our data contribute to the understanding of some signaling pathways for human HB proliferation in vitro. Simultaneous BMP/HGF induction, activation of Wnt and HH, and inhibition of TGF-β pathways created a reliable method for long-term stable large-scale expansion of HBs to obtain mature hepatocytes that may have substantial clinical applications. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-6888929
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68889292019-12-11 Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts Pan, Tingcai Chen, Yan Zhuang, Yuanqi Yang, Fan Xu, Yingying Tao, Jiawang You, Kai Wang, Ning Wu, Yuhang Lin, Xianhua Wu, Feima Liu, Yanli Li, Yingrui Wang, Guodong Li, Yin-xiong Stem Cell Res Ther Research BACKGROUND: The limited proliferative ability of hepatocytes is a major limitation to meet their demand for cell-based therapy, bio-artificial liver device, and drug tests. One strategy is to amplify cells at the hepatoblast (HB) stage. However, expansion of HBs with their bipotency preserved is challenging. Most HB expansion methods hardly maintain the bipotency and also lack functional confirmation. METHODS: On the basis of analyzing and manipulating related signaling pathways during HB (derived from human induced pluripotent stem cells, iPSCs) differentiation and proliferation, we established a specific chemically defined cocktails to synergistically regulate the related signaling pathways that optimize the balance of HB proliferation ability and stemness maintenance, to expand the HBs and investigate their capacity for injured liver repopulation in immune-deficient mice. RESULTS: We found that the proliferative ability progressively declines during HB differentiation process. Small molecule activation of Wnt or inhibition of TGF-β pathways promoted HB proliferation but diminished their bipotency, whereas activation of hedgehog (HH) signaling stimulated proliferation and sustained HB phenotypes. A cocktail synergistically regulating the BMP/WNT/TGF-β/HH pathways created a fine balance for expansion and maintenance of the bipotency of HBs. After purification, colony formation, and expansion for 20 passages, HBs retained their RNA profile integrity, normal karyotype, and ability to differentiate into mature hepatocytes and cholangiocytes. Moreover, upon transplantation into liver injured mice, the expanded HBs could engraft and differentiate into mature human hepatocytes and repopulate liver tissue with restoring hepatocyte mass. CONCLUSION: Our data contribute to the understanding of some signaling pathways for human HB proliferation in vitro. Simultaneous BMP/HGF induction, activation of Wnt and HH, and inhibition of TGF-β pathways created a reliable method for long-term stable large-scale expansion of HBs to obtain mature hepatocytes that may have substantial clinical applications. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2019-12-02 /pmc/articles/PMC6888929/ /pubmed/31791391 http://dx.doi.org/10.1186/s13287-019-1463-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pan, Tingcai
Chen, Yan
Zhuang, Yuanqi
Yang, Fan
Xu, Yingying
Tao, Jiawang
You, Kai
Wang, Ning
Wu, Yuhang
Lin, Xianhua
Wu, Feima
Liu, Yanli
Li, Yingrui
Wang, Guodong
Li, Yin-xiong
Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts
title Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts
title_full Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts
title_fullStr Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts
title_full_unstemmed Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts
title_short Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts
title_sort synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888929/
https://www.ncbi.nlm.nih.gov/pubmed/31791391
http://dx.doi.org/10.1186/s13287-019-1463-y
work_keys_str_mv AT pantingcai synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT chenyan synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT zhuangyuanqi synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT yangfan synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT xuyingying synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT taojiawang synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT youkai synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT wangning synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT wuyuhang synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT linxianhua synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT wufeima synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT liuyanli synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT liyingrui synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT wangguodong synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts
AT liyinxiong synergisticmodulationofsignalingpathwaystoexpandandmaintainthebipotencyofhumanhepatoblasts